Harness next generation sequencing with the next generation of pathogen analysis
Genpax overcomes existing analytical constraints, providing highly accurate analysis using SNP-resolution throughout.
Our processes remove background noise, increasing the resolution and usefulness of the real differences to identify strains and determine their connections.
The service is easy to adopt and compatible with all modern Illumina sequencing platforms and will support additional sequencing providers in 2024.
Genpax is built to serve many client-types, creating a truly global solution addressing Healthcare, Public Health, Food Safety, ‘One Health’, research and development, and other industries with a common scalable platform for bacterial pathogen genomics.
Rise above the noise
Genpax delivers unprecedented accuracy by increasing the detection of true differences and excluding the interference of noise.
By implementing a near-zero-error solution it becomes possible to generate fully comparable data from single and multiple sites, to detect and focus upon the markers that define transmission-linked strains and infer their connections.
Genpax addresses more of the genome than existing solutions that identify genomic differences (e.g. Sequence Typing or whole-genome SNP). The high proportion of the genome analyzed and compared is maintained as sample numbers and diversity increases.
This high resolution and low noise is vital to detect and address outbreaks in bacteria that are typically evolving at a rate of only 0 to 10 nucleotides per year per genome.
The Genpax platform is the first openly scalable high resolution, high accuracy analysis solution for pathogen detection, recognition, containment, prevention, and control.
The ability to address local outbreaks over time and space, or to compare strains from multiple users with an ‘each-against-every’ strategy for previously analyzed strains, at SNP-resolution makes Genpax fit for the genomic age.
Accuracy underpins reproducibility. Genpax is the only platform that consistently generates identical full SNP resolution results from replicates and closely-linked clinical isolates.
With our platform, all strains of a species are fully comparable within and between sequencing sites and over time with no loss in speed or quality.
Genpax delivers full analysis results within 2 hours of the sequence file receipt. Full and robust analysis regardless of the number of submitted sequences and the strains being compared.
Our rapid turnaround of clinically-actionable data allows rapid intervention which is vital for the most effective outbreak surveillance and management.
Genpax removes the need for local IT infrastructure and bioinformatics or genomic epidemiology expertise. Simply accessed through the Cloud, it is available to every laboratory with the capability to sequence.
The platform is user-friendly, easily understandable, interactive, and produces archivable reports to serve the specific needs of laboratories, public health, infection prevention and control, and other contexts.